Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 28, 2026; 32(40): 117677
Published online Oct 28, 2026. doi: 10.3748/wjg.117677
Published online Oct 28, 2026. doi: 10.3748/wjg.117677
Figure 2 Knockdown of ARPC1B suppresses the malignant phenotype of colorectal cancer cell.
A: The knockdown efficiency of ARPC1B-short hairpin RNA (shRNA) 1-3 in HT29 and SW620 cell lines; B: The proliferation of HT29 and SW620 cell lines treated or not treated with ARPC1B-shRNA (sh-ARPC1B) was detected via cell counting kit-8 assay; C: The invasion of HT29 and SW620 cell lines treated or not treated with sh-ARPC1B was detected via transwell assay; D: The apoptosis rate of HT29 and SW620 cell lines treated or not treated with sh-ARPC1B was detected via flow-cytometry assay. n = 3. scale bar = 100 μm. aP < 0.05. bP < 0.01. cP < 0.001. NC: Negative control; sh-ARPC1B: ARPC1B-short hairpin RNA; FITC: Fluorescein isothiocyanate; PI: Propidium iodide.
- Citation: Chen YL, Lin BA, Chen X, Liu XP, Huang JS. ARPC1B contributes to colorectal cancer progression and is associated with programmed death-ligand 1 expression. World J Gastroenterol 2026; 32(40): 117677
- URL: https://www.wjgnet.com/1007-9327/full/v32/i40/117677.htm
- DOI: https://dx.doi.org/10.3748/wjg.117677